Resources

Sept 20, 2021 – Press Release

Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021

Aug 20, 2021 – Announcement

First Patient Treated with
INTERCEPT Fibrinogen Complex

Aug 10, 2021 – Press Release

Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products

Aug 3, 2021 – Press Release

Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex

Nov 30, 2020 – Press Release

Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation

Oct 31, 2020 – Press Release

Emergency Medical Response Team

Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate